Boyd Peter E. (CIK 0001739816)

Latest company ownership

AQST - Aquestive Therapeutics, Inc.

Role: Officer

Shares held

268,323

Last filed at

Dec 5, 2025

Confidence Score

37.8

2025Q4

Confidence Score History

2018Q4 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Oct 15, 2025	Oct 17, 2025	Aquestive Therapeutics, Inc.	Officer	Sell	37.5	-10,000	-3.59%	✓	$70K
Sep 26, 2025	Sep 29, 2025	Aquestive Therapeutics, Inc.	Officer	Sell	37.5	-10,000	-3.47%	✓	$63K
Sep 5, 2025	Sep 8, 2025	Aquestive Therapeutics, Inc.	Officer	Sell	37.5	-15,000	-4.95%	✓	$79.5K
Mar 7, 2025	Mar 11, 2025	Aquestive Therapeutics, Inc.	Officer	Sell	91.3	+65,695	27.65%	✗	$37.9K
Mar 9, 2024	Mar 12, 2024	Aquestive Therapeutics, Inc.	Officer	Sell	46.3	-8,370	-3.40%	✗	$40.8K
Jun 14, 2022	Jun 15, 2022	Aquestive Therapeutics, Inc.	SVP-Bus. Process & Info. Tech.	Buy	85.0	+5,000	9.17%	✗	$4.1K
Jun 8, 2022	Jun 10, 2022	Aquestive Therapeutics, Inc.	SVP-Bus. Process & Info. Tech.	Buy	82.5	+2,293	4.39%	✗	$2.2K
Mar 16, 2020	Mar 18, 2020	Aquestive Therapeutics, Inc.	SVP-Bus. Process & Info. Tech.	Buy	82.5	+2,000	3.98%	✗	$3K
Aug 12, 2019	Aug 13, 2019	Aquestive Therapeutics, Inc.	SVP-Bus. Process & Info. Tech.	Buy	77.5	+600	1.21%	✗	$2.3K
Nov 21, 2018	Nov 26, 2018	Aquestive Therapeutics, Inc.	SVP-Operations/Value Delivery	Buy	60.0	+200	0.40%	✗	$2K